መነሻ › የጡንቻ ካንሰር › ኢሊኖይ › Waukegan
በWaukegan፣ IL ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጡንቻ ካንሰር የሚደረጉ 12 ጥናቶች በWaukegan እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- AMG Libertyville - Oncology, Libertyville · 8 ማይል ርቀት
- Condell Memorial Hospital, Libertyville · 8 ማይል ርቀት
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- City of Hope Chicago, Zion · 6 ማይል ርቀት
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- City of Hope, Chicago, Zion · 6 ማይል ርቀት
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 ማይል ርቀት
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- City of Hope - Chicago, Zion · 6 ማይል ርቀት
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 ማይል ርቀት
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- City of Hope® Cancer Center Chicago, Zion · 6 ማይል ርቀት
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 ማይል ርቀት
- AMG Libertyville - Oncology, Libertyville · 8 ማይል ርቀት
- Condell Memorial Hospital, Libertyville · 8 ማይል ርቀት
- እና 1 ተጨማሪ
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 3
- City of Hope - Cancer Center Chicago, Zion · 6 ማይል ርቀት
E-Mindfulness Approaches for Living After Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 ማይል ርቀት
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 ማይል ርቀት
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Midwestern Regional Medical Center, Zion · 6 ማይል ርቀት
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 ማይል ርቀት
- AMG Libertyville - Oncology, Libertyville · 8 ማይል ርቀት
- እና 2 ተጨማሪ
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- AMG Libertyville - Oncology, Libertyville · 8 ማይል ርቀት
- Condell Memorial Hospital, Libertyville · 8 ማይል ርቀት
በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች
- New York City, NY136 ጥናቶች
- Houston, TX126 ጥናቶች
- Boston, MA112 ጥናቶች
- Nashville, TN81 ጥናቶች
- Los Angeles, CA73 ጥናቶች
- Edison, NJ68 ጥናቶች
- St. Louis, MO64 ጥናቶች
- Queens, NY64 ጥናቶች
- Durham, NC64 ጥናቶች
- Chicago, IL59 ጥናቶች
- Philadelphia, PA56 ጥናቶች
- Dallas, TX55 ጥናቶች
በWaukegan ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር16 ጥናቶች
- የሳንባ ካንሰር16 ጥናቶች
- አልሰራቲቭ ኮላይቲስ7 ጥናቶች
- የኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ)7 ጥናቶች
- የእንቁላል ካንሰር6 ጥናቶች
- Metastatic Cancer6 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ6 ጥናቶች
- የኮሎሬክታል ካንሰር6 ጥናቶች
- የፕሮስቴት ካንሰር6 ጥናቶች
- ሜላኖማ5 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ5 ጥናቶች
- የክሮን በሽታ5 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።